Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Rittgen

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
British Journal of Cancer|July 11, 2002
Primary staging and follow-up in melanoma patients--monocenter evaluation of methods, costs and patient survivalU Hofmann, M Szedlak, W Rittgen, et al.
Die Naturwissenschaften|December 1, 1977
Cell filtration by isolated rat liverE Friedrich, R Süss, H Sinn, et al.
International Journal of Cancer|November 14, 1997
Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRB, p16INK4A) in childhood acute lymphoblastic leukemiaM Volm, R Koomägi, G Stammler, et al.
Leukemia|October 3, 2002
In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemiaC Schwänen, T Hecker, G Hübinger, et al.
International Journal of Cancer|April 3, 2001
Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-specific RT-PCRJ Lacroix, H D Becker, S M Woerner, et al.
Cancer Biology & Therapy|November 19, 2005
Corticosteroid-induced chemotherapy resistance in urological cancersC Zhang, J Mattern, A Haferkamp, et al.
Mutagenesis|January 5, 2001
Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytesP Schmezer, N Rajaee-Behbahani, A Risch, et al.
International Journal of Cancer|March 10, 2001
Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancerN Rajaee-Behbahani, P Schmezer, A Risch, et al.
British Journal of Cancer|April 23, 2005
Lack of clinical efficacy of imatinib in metastatic melanomaS Ugurel, R Hildenbrand, A Zimpfer, et al.
Cancer Letters|December 13, 2005
Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapyC Zhang, A Kolb, J Mattern, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|July 11, 2002
Primary staging and follow-up in melanoma patients--monocenter evaluation of methods, costs and patient survivalU Hofmann, M Szedlak, W Rittgen, et al.
Die Naturwissenschaften|December 1, 1977
Cell filtration by isolated rat liverE Friedrich, R Süss, H Sinn, et al.
International Journal of Cancer|November 14, 1997
Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRB, p16INK4A) in childhood acute lymphoblastic leukemiaM Volm, R Koomägi, G Stammler, et al.
Leukemia|October 3, 2002
In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemiaC Schwänen, T Hecker, G Hübinger, et al.
International Journal of Cancer|April 3, 2001
Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-specific RT-PCRJ Lacroix, H D Becker, S M Woerner, et al.
Cancer Biology & Therapy|November 19, 2005
Corticosteroid-induced chemotherapy resistance in urological cancersC Zhang, J Mattern, A Haferkamp, et al.
Mutagenesis|January 5, 2001
Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytesP Schmezer, N Rajaee-Behbahani, A Risch, et al.
International Journal of Cancer|March 10, 2001
Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancerN Rajaee-Behbahani, P Schmezer, A Risch, et al.
British Journal of Cancer|April 23, 2005
Lack of clinical efficacy of imatinib in metastatic melanomaS Ugurel, R Hildenbrand, A Zimpfer, et al.
Cancer Letters|December 13, 2005
Dexamethasone desensitizes hepatocellular and colorectal tumours toward cytotoxic therapyC Zhang, A Kolb, J Mattern, et al.
Pageof 3